Tara Spires-Jones

Director of the Centre for Discovery Brain Sciences at the University of Edinburgh, Group Leader in the UK Dementia Research Institute, and Past President of the British Neuroscience Association 

This study by Adesuyan and colleagues found an association between prescription of drugs used to treat erectile dysfunction and a reduced risk of developing Alzheimer’s disease. The study was well-conducted, and authors are appropriately cautious in their interpretation of the data. This study does not conclusively prove that erectile dysfunction drugs reduce Alzheimer’s risk but provide good evidence that this type of drug is worth further study in future.

EN